Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | HPGD | P15428 | 4/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.36 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | FYN | P06241 | 2/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | AHR | P35869 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4129543 | 0.89 | ALDH1A1 (0.59) | ALDH1A1HPGDHSD17B10L3MBTL1TSHR | |
| SCHEMBL4137635 | 0.89 | ALDH1A1 (0.44) | ALDH1A1HPGDHSD17B10L3MBTL1TSHR | |
| SCHEMBL3978100 | 0.84 | ALDH1A1 (0.70) | ALDH1A1HPGDHSD17B10L3MBTL1TSHR | |
| SCHEMBL3743600 | 0.83 | CYP1A2 (0.59) | ALDH1A1HPGDL3MBTL1TSHRCYP1A2 | |
| SCHEMBL15497853 | 0.83 | ALDH1A1 (0.61) | ALDH1A1HPGDHSD17B10L3MBTL1TSHR | |
| SCHEMBL2083628 | 0.82 | ALDH1A1 (0.52) | ALDH1A1HPGDHSD17B10L3MBTL1TSHR | |
| SCHEMBL29949905 | 0.81 | CYP1A2 (0.51) | ALDH1A1HPGDHSD17B10L3MBTL1TSHR | |
| SCHEMBL3683915 | 0.81 | CYP1A2 (0.51) | ALDH1A1HPGDHSD17B10L3MBTL1TSHR | |
| SCHEMBL3686039 | 0.81 | CYP1A2 (0.51) | ALDH1A1HPGDHSD17B10L3MBTL1TSHR | |
| SCHEMBL2083837 | 0.79 | CYP1A2 (0.45) | ALDH1A1HPGDHSD17B10L3MBTL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101155896-B | Organic electroluminescent device | MERCK PATENT GMBH | 2012-08-29 | — | — | CN | disclosed |
| US-20080166593-A1 | Organic Electroluminescent Devices | MERCK PATENT GMBH (DE) | 2008-07-10 | — | — | US | disclosed |
| US-20080166593-A1 | Organic Electroluminescent Devices | MERCK PATENT GMBH (DE) | 2008-07-10 | — | — | US | disclosed |
| US-20080166593-A1 | Organic Electroluminescent Devices | MERCK PATENT GMBH (DE) | 2008-07-10 | — | — | US | disclosed |
| CN-101155896-A | Organic electroluminescent device | MERCK PATENT GMBH (DE) | 2008-04-02 | — | — | CN | disclosed |
| EP-1871856-A1 | ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2008-01-02 | — | — | EP | disclosed |
| WO-2006108498-A1 | ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2006-10-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080166593-A1 | Organic Electroluminescent Devices | OR10J3, DDT, EML4 | ALDH1A1 610/4885HPGD 2780/4885HSD17B10 2215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.